Fri 20 Nov
Trending
Advertising · PolicyGCC18 Nov 2026

UAE drug regulator restates influencer ban, allows regulated prescription-drug ads.

The Emirates Drug Establishment (EDE) has reminded advertisers that social media influencers may not advertise, promote or endorse medical products in the UAE. At the same session it set out rules that let prescription-only medicines be advertised under approved regulatory controls.

The regulator held a customer council on medical product advertising at the Government Accelerators Centre in Emirates Towers, Dubai, with partners, customers and industry representatives. Its message was that every advertisement needs EDE approval before it is published or circulated, through its advertisement licensing system. The rules cover print, audio and visual material such as outdoor screens, as well as websites, social platforms and other digital channels. Claims must be truthful and not misleading, stay within what the product is approved for, spell out risks and side effects, and come with disclaimers that fit the product and who will see the ad. Ads must not push the public towards self-diagnosis or self-prescription without a healthcare professional involved.

The council also covered enforcement: inspection across media channels, how non-compliant content is handled, and coordination with other authorities to have it taken down. The National, which reported the update on 19 November, linked it to an August circular from the Dubai Health Authority reminding private healthcare facilities and medical professionals of the rules for advertising on social media and warning of disciplinary action. Influencers and before-and-after posts are a common way for Dubai's aesthetics clinics to find patients.

Some things are not spelled out. The National's headline calls it a ban, but the EDE's own release describes the influencer rule as a prohibition it was reiterating, not a new one. Neither source says when the prescription-medicine rules take effect, what penalties apply, or exactly which products count as medical products.

Our read: for pharma, clinic and health brands working with UAE creators, influencer advertising, promotion or endorsement of medical products should be treated as off the table, and every asset, digital ones included, needs EDE approval before it goes live. Prescription-medicine advertising looks set to open up, but agencies should plan for an approval step on every execution.

Why it matters

Health brands and their agencies in the UAE need EDE approval for every ad and cannot use influencers to promote medical products, while prescription-drug ads are being introduced under controls, with no start date given.

Related trends.

AdvertisingDataGlobal

Trade Desk study: balanced media plans persuade better than social-heavy ones

The Trade Desk has published brain-response research saying media plans spread across channels persuade people better than plans weighted to social. The adtech company, working with PA Consulting and Brainsights, reports a 47% lift in persuasion and a 1.6 times advantage over social-heavy plans.

Why it mattersIt puts numbers on a familiar argument against social-first plans, but they come from a company that sells the alternative, and the coverage does not give the method.

20 Nov 2026Source ↗
AdvertisingDealGCC

Equiti signs as SailGP event partner for Dubai and Abu Dhabi races

Fintech group Equiti has signed an event partnership with the 2026 Rolex SailGP Championship, beginning with the league's two UAE race weekends. It starts at the Emirates Dubai Sail Grand Prix on 21–22 November and runs to the Abu Dhabi final on 28–29 November.

Why it mattersA fintech brand is buying into SailGP at event level for its two UAE weekends. Value and term are undisclosed, so the test is whether it renews.

20 Nov 2026Source ↗

Related work.